ClinicalTrials.Veeva

Menu

Viscosity of Fibre Predicts Cholesterol-lowering in Healthy Individuals

U

Unity Health Toronto

Status and phase

Completed
Phase 2

Conditions

Healthy
Lipidemia

Treatments

Dietary Supplement: Wheat Bran
Dietary Supplement: Viscous Fibre Blend
Dietary Supplement: Psyllium

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT03741621
viscosity and cholesterol

Details and patient eligibility

About

To investigate the role of fibre viscosity (low, medium, high) in lowering cholesterol in healthy individuals

Enrollment

23 patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

-healthy individuals

Exclusion criteria

  • regular alcohol consumption
  • regular smoking

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

23 participants in 3 patient groups

High Viscosity
Experimental group
Description:
viscous fibre blend added to breakfast cereals consumed in the context of a typical North American diet for 3 weeks duration
Treatment:
Dietary Supplement: Viscous Fibre Blend
Medium Viscosity
Experimental group
Description:
Kellogg's Bran buds with psyllium breakfast cereal consumed in the context of a typical North American diet for 3 weeks duration
Treatment:
Dietary Supplement: Psyllium
Low Viscosity
Experimental group
Description:
Kellogg's All Bran breakfast cereal consumed in the context of a typical North American diet for 3 weeks duration
Treatment:
Dietary Supplement: Wheat Bran

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems